CFCareForward Patient Support Program

CFCareForward Patient Support Program

CFCareForward offers nutritional products at no charge to eligible patients with cystic fibrosis (CF), as well as financial and educational resources to patients and families touched by CF.

Nutritional support

  • Multivitamins in softgel, chewable, and liquid formulations.
  • A variety of nutritional drinks and bars.

Financial support

Educational resources

  • Helpful information about exocrine pancreatic insufficiency due to CF and CREON are available online at CREON.com, as well as a variety of other educational materials such as patient emails, brochures, and pamphlets.

For more information, visit CFCareForward.com or call 1-855-CARE4WD (1-855-227-3493).

IMPORTANT SAFETY INFORMATION

  • Fibrosing colonopathy is associated with high-dose use of pancreatic enzyme replacement in the treatment of cystic fibrosis patients. Exercise caution when doses of CREON exceed 2,500 lipase units/kg of body weight per meal (or greater than 10,000 lipase units/kg of body weight per day).
  • To avoid irritation of oral mucosa, care should be taken to ensure that CREON is not crushed, chewed, or retained in the mouth. CREON should always be taken with food.
  • Porcine-derived pancreatic enzyme products contain purines. Caution should be exercised when prescribing CREON to patients with gout, renal impairment, or hyperuricemia.
  • There is theoretical risk of viral transmission with all pancreatic enzyme products including CREON.
  • Exercise caution when administering pancrelipase to a patient with a known allergy to proteins of porcine origin.
  • Adverse reactions that occurred in at least 2 cystic fibrosis patients (greater than or equal to 4%) receiving CREON were vomiting, dizziness, and cough.
  • Adverse reactions that occurred in at least 1 chronic pancreatitis or pancreatectomy patient (greater than or equal to 4%) receiving CREON were hyperglycemia, hypoglycemia, abdominal pain, abnormal feces, flatulence, frequent bowel movements, and nasopharyngitis.
  • CREON is not interchangeable with any other pancrelipase product.

INDICATIONS

CREON® (pancrelipase) Delayed-Release Capsules is a pancrelipase which is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.

OTHER TOPICS

CREON Co-pay Assistance

Make sure your patients receive the CREON co-pay card.

Your Nutrition Partner

Nutritional products offered through the CFCareForward support program.

Contact a Representative

Request CREON co-pay cards, product samples, and more.